Cryoport Net Worth
Cryoport Net Worth Breakdown | CYRX |
Cryoport Net Worth Analysis
Cryoport's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Cryoport's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Cryoport's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Cryoport's net worth analysis. One common approach is to calculate Cryoport's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Cryoport's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Cryoport's net worth. This approach calculates the present value of Cryoport's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Cryoport's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Cryoport's net worth. This involves comparing Cryoport's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Cryoport's net worth relative to its peers.
Enterprise Value |
|
To determine if Cryoport is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cryoport's net worth research are outlined below:
| Cryoport had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 233.25 M. Net Loss for the year was (99.59 M) with profit before overhead, payroll, taxes, and interest of 103.87 M. | |
| Cryoport currently holds about 550.62 M in cash with (757 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 11.35, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cryoport has a poor financial position based on the latest SEC disclosures | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from thelincolnianonline.com: Cryoport, Inc. Receives Consensus Recommendation of Moderate Buy from Analysts |
Cryoport uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cryoport. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cryoport's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 22nd of February 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 22nd of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Cryoport's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cryoport is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cryoport backward and forwards among themselves. Cryoport's institutional investor refers to the entity that pools money to purchase Cryoport's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Axa Sa | 2024-09-30 | 1.1 M | Geode Capital Management, Llc | 2024-09-30 | 1.1 M | State Street Corp | 2024-09-30 | 1 M | Dimensional Fund Advisors, Inc. | 2024-09-30 | 786.9 K | Blackstone Inc | 2024-09-30 | 453.4 K | Northern Trust Corp | 2024-09-30 | 451.4 K | Point72 Asset Management, L.p. | 2024-09-30 | 419.9 K | Silvercrest Asset Management Group Llc | 2024-09-30 | 419.7 K | Wcm Investment Management | 2024-09-30 | 412.3 K | Brown Capital Management, Llc | 2024-09-30 | 5.2 M | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 4.7 M |
Follow Cryoport's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 407.31 M.Market Cap |
|
Project Cryoport's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.15) | (0.16) | |
| Return On Capital Employed | (0.13) | (0.12) | |
| Return On Assets | (0.10) | (0.11) | |
| Return On Equity | (0.20) | (0.19) |
When accessing Cryoport's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Cryoport's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cryoport's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Cryoport's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cryoport. Check Cryoport's Beneish M Score to see the likelihood of Cryoport's management manipulating its earnings.
Evaluate Cryoport's management efficiency
Cryoport has return on total asset (ROA) of (0.0512) % which means that it has lost $0.0512 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.3315) %, meaning that it created substantial loss on money invested by shareholders. Cryoport's management efficiency ratios could be used to measure how well Cryoport manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.16 in 2024. Return On Capital Employed is likely to rise to -0.12 in 2024. At this time, Cryoport's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 443.8 M in 2024, whereas Other Assets are likely to drop 0.95 in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 10.03 | 10.54 | |
| Tangible Book Value Per Share | 3.82 | 4.01 | |
| Enterprise Value Over EBITDA | (16.95) | (17.79) | |
| Price Book Value Ratio | 1.54 | 1.62 | |
| Enterprise Value Multiple | (16.95) | (17.79) | |
| Price Fair Value | 1.54 | 1.62 | |
| Enterprise Value | 1.1 B | 1.2 B |
The strategic initiatives led by Cryoport's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 1.7703 | Revenue 226.1 M | Quarterly Revenue Growth 0.009 | Revenue Per Share 4.597 | Return On Equity (0.33) |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cryoport insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cryoport's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cryoport insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cryoport Corporate Filings
F4 | 4th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 3rd of September 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
Cryoport Earnings per Share Projection vs Actual
Cryoport Corporate Management
| Thomas Heinzen | Vice Relations | Profile | |
| Tony Ippolito | VP Counsel | Profile | |
| Phil Wilson | LLC Systems | Profile | |
| Edward Zecchini | Senior Officer | Profile |
Additional Tools for Cryoport Stock Analysis
When running Cryoport's price analysis, check to measure Cryoport's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cryoport is operating at the current time. Most of Cryoport's value examination focuses on studying past and present price action to predict the probability of Cryoport's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cryoport's price. Additionally, you may evaluate how the addition of Cryoport to your portfolios can decrease your overall portfolio volatility.